insulin vs glp-1 Glucagon-like peptide-1 Schematic of action of GLP-1

Modern pharmaceutical-style presentation developed for clinic and retail visibility

Individuals with certain medical conditions or who take certain medications should consult with a healthcare provider prior to initiating

New England Journal of Medicine 393 (11)

This helps our team understand your background before you walk in the door

Many patients pair their program with peptide therapy and wellness support to round out their metabolic plan

Discussion We report a large-scale GWAS of treatment response to GLP1 medications and identify a missense variant in GLP1R , which encodes the therapeutic target of semaglutide and tirzepatide that associates with BMI loss